Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,227 public trials 1,016 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).

NCT02321046

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Khanti-Manskiysk, Russia
  • Research Site Novisibirsk, Russia
  • Research Site Arkhangelsk, Russia
  • Research Site Barnaul, Russia
View all 26 locations
View Trial Details
Completed

Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer

NCT00864266

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Department of Pneumology Clinique Saint-Luc Bouge, Belgium
  • Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium
  • Service de Pneumologie Hôpital Erasme Brussels, Belgium
  • Department of Pneumology Hôpital Saint-Joseph Gilly, Belgium
View Trial Details
Completed

Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).

NCT03562819

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Reserch Site Punjab, Chandigarh, India
  • Research Site Bengaluru, Karnataka, India
  • Research Site Kerala, Kozhikode, India
  • Research Site Mumbai, Maharashtra, India
View all 14 locations
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

NCT01803282

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +29 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • San Diego Pacific Oncology and Hematology Associates, Inc. Encinitas, California, United States
View all 18 locations
View Trial Details
Completed

A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer

NCT01380769

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • State Medical Institution Republican Oncology Center Saransk, Respublika Mordoviya, Russia
  • State Medical Institution Republic Clinical Oncological Center under the Healthcare Ministry of Tatarstan Republic Kazan', Tatarstan Republic, Russia
  • Arkhangelsk Regional Clinical Oncology Center Arkhangelsk, Russia
  • State Healthcare Institution: Bryansk Regional Oncology Center Bryansk, Russia
View all 25 locations
View Trial Details
Completed

Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

NCT02289690

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Mayo Clinic - Scottsdale /ID# 129127 Scottsdale, Arizona, United States
  • Univ of Colorado Cancer Center /ID# 129220 Aurora, Colorado, United States
  • Emory University Hospital /ID# 141682 Atlanta, Georgia, United States
  • Georgia Regents University /ID# 148567 Augusta, Georgia, United States
View all 62 locations
View Trial Details

Related conditions